Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

UBE2S activates NF-κB signaling by binding with IκBα and promotes metastasis of lung adenocarcinoma cells
Jhih-Yun Ho, Hsin‐Ying Lu, Hsing-Hsien Cheng, et al.
Cellular Oncology (2021) Vol. 44, Iss. 6, pp. 1325-1338
Open Access | Times Cited: 21

Showing 21 citing articles:

Flavokawain A suppresses the vasculogenic mimicry of HCC by inhibiting CXCL12 mediated EMT
Ting Xiao, Jiali Bao, Jiao Tian, et al.
Phytomedicine (2023) Vol. 112, pp. 154687-154687
Open Access | Times Cited: 16
UBE2S promotes the development of ovarian cancer by promoting PI3K/AKT/mTOR signaling pathway to regulate cell cycle and apoptosis
Mengjun Zhang, Yuan Liu, Yue Yin, et al.
Molecular Medicine (2022) Vol. 28, Iss. 1
Open Access | Times Cited: 19
UBE2S, downregulated by miR-152-3p, facilitates prostate cancer progression through the PTEN-mediated AKT/mTOR pathway
Chunhui Wang, Gang Zhang, Ying Jiang, et al.
Human Molecular Genetics (2025)
Closed Access
Construction of ubiquitination-related risk model for predicting prognosis in lung adenocarcinoma
Dawei Sun, Xiaohong Duan, Ning Li, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
[Effect of CMTM6 on PD-L1 in
Wei Fu, Jing Ning, Wei‐Wei Fu, et al.
PubMed (2025) Vol. 57, Iss. 2, pp. 245-252
Closed Access
A prognostic model of drug tolerant persister-related genes in lung adenocarcinoma based on single cell and bulk RNA sequencing data
Zhonghai Du, Tongtong Zhang, Yanke Lin, et al.
Heliyon (2023) Vol. 9, Iss. 11, pp. e20708-e20708
Open Access | Times Cited: 7
Diverse roles of UBE2S in cancer and therapy resistance: Biological functions and mechanisms
Mengjun Zhang, Jialin Wang, Zidi Zhang, et al.
Heliyon (2024) Vol. 10, Iss. 2, pp. e24465-e24465
Open Access | Times Cited: 2
A Pan-Cancer Analysis of UBE2S in Tumorigenesis, Prognosis, Pathway, Immune Infiltration and Evasion, and Therapy Response from an Immune-Oncology Perspective
Haili Bao, Yi Luo, Guoshan Ding, et al.
Journal of Oncology (2022) Vol. 2022, pp. 1-35
Open Access | Times Cited: 8
Identification of two molecular subtypes and a novel prognostic model of lung adenocarcinoma based on a cuproptosis-associated gene signature
Jinlin Zhou, Dehe Chen, Shiguo Zhang, et al.
Frontiers in Genetics (2023) Vol. 13
Open Access | Times Cited: 4
Cancer invasion and metastasis: Insights from murine pubertal mammary gland morphogenesis
John Maringa Githaka, Leila Pirayeshfard, Ing Swie Goping
Biochimica et Biophysica Acta (BBA) - General Subjects (2023) Vol. 1867, Iss. 8, pp. 130375-130375
Open Access | Times Cited: 4
Zebrafish in Lung Cancer Research
Xiaodi Wu, Xin Hua, Ke Xu, et al.
Cancers (2023) Vol. 15, Iss. 19, pp. 4721-4721
Open Access | Times Cited: 4
Identification of distinct tumor cell patterns with single-cell RNA sequencing integrating primary lung adenocarcinoma and brain metastasis tumor
Xi Wang, Dainan Zhang, Xiudong Guan, et al.
Translational Lung Cancer Research (2023) Vol. 12, Iss. 3, pp. 547-565
Open Access | Times Cited: 3
The prognostic effect of metastasis patterns on overall survival in organ metastatic lung adenocarcinoma
Xiaowei Tie, Wang Jin, Yong Wang, et al.
Medicine (2023) Vol. 102, Iss. 14, pp. e33297-e33297
Open Access | Times Cited: 3
Long Noncoding RNA 00472: A Novel Biomarker in Human Diseases
Danyang Ren, Xin-rong Yuan, Cai‐Xia Tu, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 5
Expression patterns of platinum resistance-related genes in lung adenocarcinoma and related clinical value models
Zhe Wang, Lin Mu, Feng He, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 3
[High expression of UBE2S promotes progression of hepatocellular carcinoma by increasing cancer cell stemness].
Hui Chen, Zhenlin Li, Mu Wang, et al.
PubMed (2024) Vol. 44, Iss. 3, pp. 455-464
Closed Access
UBE2S facilitates glioblastoma progression through activation of the NF-κB pathway via attenuating K11-linked ubiquitination of AKIP1
Zhibin Han, Lin Xu, Aowen Wang, et al.
International Journal of Biological Macromolecules (2024) Vol. 278, pp. 134426-134426
Open Access
Identification of fatty acid-related subtypes, the establishment of a prognostic signature, and immune infiltration characteristics in lung adenocarcinoma
Yuzhi Wang, Xiaoxiao Huang, Hong Fan, et al.
Aging (2023) Vol. 15, Iss. 10, pp. 4202-4235
Open Access | Times Cited: 1
UBE2S targets RPL26 for ubiquitination and degradation to promote non-small cell lung cancer progression via regulating c-Myc.
Dalian Gong, Xinxu Rao, Ziqian Min, et al.
PubMed (2023) Vol. 13, Iss. 8, pp. 3705-3720
Closed Access
As a Potential Predictor of Pan-Cancer, UBE2S is Related to Tumor-Associated Macrophage Infiltration
Haodi Yue, Jialin Wang, Siyu Hou, et al.
Future Oncology (2023) Vol. 19, Iss. 29, pp. 1961-1978
Closed Access
Flavokawain A suppresses the vasculogenic mimicry of HCC by inhibiting CXCL12 mediated EMT
Ting Xiao, Jiali Bao, Rong Lin, et al.
Authorea (Authorea) (2022)
Open Access
Page 1

Scroll to top